Safety and Efficacy of 90Y Zevalin in Nonmyeloablative Transplantation for Lymphoid Malignancies

NCT00048737 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

70

Enrollment

OTHER

Sponsor class

Conditions

Lymphoma
Leukemia

Interventions

DRUG: Zevalin Radioimmunotherapy
DRUG: Rituximab
DRUG: Fludarabine
DRUG: Cyclophosphamide
PROCEDURE: Allogeneic Stem Cell Transplantation

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]